Bim is a suppressor of Myc-induced mouse B cell leukemia
AUTOR(ES)
Egle, Alexander
FONTE
National Academy of Sciences
RESUMO
Impaired apoptosis is now recognized to be central to tumor development. Bcl2, activated by chromosomal translocation in human follicular lymphoma, promotes oncogenesis by inhibiting apoptosis. Bim, a distant proapoptotic relative, is emerging as a major physiologic antagonist of Bcl2. Here, we show that loss of Bim is oncogenic. Bim protein levels were elevated in the apoptosis-prone B lymphoid cells of Eμ-Myc-transgenic mice, and Bim-mutant Eμ-Myc mice had increased numbers of IgM-bearing B cells. Eμ-Myc-expressing B lymphoid cells deficient in Bim were refractory to apoptosis induced in vitro by cytokine deprivation or antigen receptor cross-linking. Thus, Bim is induced by Myc in B cells and mediates apoptosis. Remarkably, inactivation of even a single allele of Bim accelerated Myc-induced development of tumors, particularly acute B cell leukemia. None of the primary tumors from Bim+/- Eμ-Myc mice displayed loss of the second allele of Bim. These findings indicate that Bim is a tumor suppressor, at least in B lymphocytes, and is haploinsufficient. Whereas the p19Arf/p53 pathway is frequently mutated in tumors arising in Bim+/+ Eμ-Myc mice, it was unaffected in most Bim-deficient tumors, indicating that Bim reduction is an effective alternative to loss of p53 function.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=395940Documentos Relacionados
- Id2 Is Dispensable for Myc-Induced Epidermal Neoplasia
- Participation of cyclin A in Myc-induced apoptosis.
- Developmental Context Determines Latency of MYC-Induced Tumorigenesis
- Disruption of the ARF–Mdm2–p53 tumor suppressor pathway in Myc-induced lymphomagenesis
- Werner syndrome protein limits MYC-induced cellular senescence